TOVIAZ 4 MG Israel - English - Ministry of Health

toviaz 4 mg

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - tablets sustained release - fesoterodine fumarate 4 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

TOVIAZ 8 MG Israel - English - Ministry of Health

toviaz 8 mg

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - tablets sustained release - fesoterodine fumarate 8 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

Mingocare 4 mg prolonged-release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

mingocare 4 mg prolonged-release tablets

ceres pharma - fesoterodine fumarate - prolonged-release tablet - fesoterodine

Mingocare 8 mg prolonged-release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

mingocare 8 mg prolonged-release tablets

ceres pharma - fesoterodine fumarate - prolonged-release tablet - fesoterodine

Fesoterodine AB 4 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fesoterodine ab 4 mg tabl. prol.-rel.

aurobindo sa-nv - fesoterodine fumarate 4 mg - eq. fesoterodine 3,1 mg - prolonged-release tablet - fesoterodine

Fesoterodine AB 8 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fesoterodine ab 8 mg tabl. prol.-rel.

aurobindo sa-nv - fesoterodine fumarate 8 mg - eq. fesoterodine 6,2 mg - prolonged-release tablet - fesoterodine